Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
9.73
+0.37 (3.95%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Ardent Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Ardent Health stock have an average target of 12.56, with a low estimate of 9.00 and a high estimate of 14. The average target predicts an increase of 29.09% from the current stock price of 9.73.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Maintains $12 | Hold | Maintains | $12 | +23.33% | Jun 11, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $10 → $9 | Sell | Maintains | $10 → $9 | -7.50% | Jun 9, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $12 | Hold | Maintains | $12 | +23.33% | Jun 8, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 3, 2026 |
| UBS | UBS | Buy Reiterates $14 | Buy | Reiterates | $14 | +38.75% | Jun 3, 2026 |
Financial Forecast
Revenue This Year
6.54B
from 6.32B
Increased by 3.45%
Revenue Next Year
6.84B
from 6.54B
Increased by 4.57%
EPS This Year
1.33
from 1.54
Decreased by -13.87%
EPS Next Year
1.32
from 1.33
Decreased by -0.75%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.6B | 6.9B | |
| Avg | 6.5B | 6.8B | |
| Low | 6.4B | 6.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.2% | 6.1% | |
| Avg | 3.4% | 4.6% | |
| Low | 1.8% | 0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.56 | 1.62 | |
| Avg | 1.33 | 1.32 | |
| Low | 1.10 | 1.10 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0% | 21.8% | |
| Avg | -13.9% | -0.8% | |
| Low | -28.8% | -17.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.